Mizolastine
Back to searchMolecule Structure
Scientific Name
Mizolastine
Description of the Drug
Mizolastine is a second-generation non-sedating antihistamine used to treat symptoms of allergic rhinoconjunctivitis and urticaria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12523
http://www.drugbank.ca/drugs/DB12523
Brand Name(s)
Mizollen
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5061 | |
| PharmGKB | PA166129535 | |
| Human Metabolome Database | HMDB0240233 | |
| DrugBank | DB12523 | |
| PubChem: Thomson Pharma | 14783219 | 14856657 |
| PubChem | 65906 | |
| LINCS | LSM-5377 | |
| Nikkaji | J546.910D | |
| BindingDB | 22877 | |
| EPA CompTox Dashboard | DTXSID5046801 | |
| DrugCentral | 1824 | |
| ChemicalBook | CB7150058 | |
| Guide to Pharmacology | 10102 | |
| rxnorm | MIZOLASTINE | |
| PubChem: Drugs of the Future | 12014077 | |
| ChEBI | 31857 | |
| ZINC | ZINC000013831810 |
